Latest Period
Q1 2026
Security Snapshot
SpyGlass Pharma, Inc. - Common Stock, $0.00001 par value per share (SGP) Institutional Ownership
CUSIP: 85220G109
13F Institutional Holders and Ownership History for Q1 2026
Institutions Reporting
35
Shares (Excl. Options)
25,353,391
Price
$25.91
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.00001 par value per share
- Symbol
- SGP on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 25,353,391
- Total 13F value
- $655,443,297
- Portfolio coverage rank
- 0%
- Share change
- +24,850,189
- Value change
- +$642,405,332
- Number of holders
- 35
- Shares outstanding
- 33,491,317
- SEC-reported price per share
- $23.82
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SGP - SpyGlass Pharma, Inc. - Common Stock, $0.00001 par value per share is tracked under CUSIP 85220G109.
- 35 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Latest quarter on this page is Q1 2026.
- Additional quarter-over-quarter change detail appears as history expands.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 35 institutions filings for Q1 2026.
Security key
85220G109
Latest holder period
Q1 2026
13F holders
35
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
SGP full holder history
SpyGlass Pharma, Inc. SEC filings
SpyGlass Pharma, Inc. company facts
SpyGlass Pharma, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 85220G109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
SGP
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 24% | 8,022,639 | RA Capital Management, L.P. | 09 Feb 2026 | ||||
| New Enterprise Associates 17, L.P. | 22% | 7,393,823 | Ali Behbahani | 09 Feb 2026 | ||||
| Vensana Capital I GP, LLC | 9.9% | 3,312,141 | Kirk Nielsen | 09 Feb 2026 | ||||
| Sands Capital Life Sciences Pulse Fund III (DE), L.P. | 7.8% | 2,500,012 | SANDS FRANK M. | 06 Feb 2026 | ||||
| Gilde Healthcare Holding B.V. | 6.6% | 2,187,513 | Gilde Healthcare Holding B.V. | 09 Feb 2026 | ||||
| Samsara BioCapital, L.P. | 6.3% | 2,109,953 | Srinivas Akkaraju | 09 Feb 2026 |
As of 31 Mar 2026, 35 institutional investors reported holding 25,353,391 shares of SpyGlass Pharma, Inc. - Common Stock, $0.00001 par value per share (SGP). This represents 76% of the company’s total 33,491,317 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
75%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 24% | 8,021,117 | 2.2% | $207,827,141 | |
| NEA Management Company, LLC | 22% | 7,392,301 | 11% | $191,534,519 | |
| Sands Capital Alternatives, LLC | 7.5% | 2,500,012 | 15% | $64,775,311 | |
| SAMSARA BIOCAPITAL, LLC | 6.3% | 2,109,953 | 5.3% | $54,668,882 | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.1% | 704,440 | 0% | $18,253,000 | |
| Vestal Point Capital, LP | 2% | 666,760 | 0.48% | $17,275,752 | |
| JPMORGAN CHASE & CO | 1.7% | 577,109 | 0% | $13,487,037 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.6% | 550,000 | 0.17% | $14,250,500 | |
| MILLENNIUM MANAGEMENT LLC | 1.4% | 468,794 | 0.01% | $12,146,453 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.3% | 434,813 | 0% | 0% | $11,266,005 |
| First Light Asset Management, LLC | 1.1% | 375,000 | 0.87% | $9,716,250 | |
| FRANKLIN RESOURCES INC | 0.9% | 300,000 | 0% | $7,773,000 | |
| Affinity Asset Advisors, LLC | 0.75% | 250,000 | 0.38% | $6,477,500 | |
| Aberdeen Group plc | 0.66% | 220,454 | 0.01% | $5,711,963 | |
| BlackRock, Inc. | 0.43% | 144,739 | 0% | $3,750,187 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.38% | 126,540 | 0% | $3,280,687 | |
| Monashee Investment Management LLC | 0.28% | 95,000 | 1.3% | $2,461,450 | |
| VANGUARD FIDUCIARY TRUST CO | 0.18% | 59,782 | 0% | 0% | $1,548,952 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.18% | 59,610 | 0% | $1,544,495 | |
| Alyeska Investment Group, L.P. | 0.17% | 57,000 | 0% | $1,476,870 | |
| TD Asset Management Inc | 0.14% | 47,580 | 0% | $1,232,798 | |
| AMERIPRISE FINANCIAL INC | 0.13% | 44,477 | 0% | $1,152,399 | |
| MARSHALL WACE, LLP | 0.09% | 29,348 | 0% | $760,406 | |
| BANK OF AMERICA CORP /DE/ | 0.08% | 28,020 | 0% | $725,998 | |
| NORTHERN TRUST CORP | 0.06% | 20,862 | 0% | $540,534 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
1
Latest
Q1 2026
Rows shown
1-1 of 1
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 25,353,391 | $655,443,297 | +$642,405,332 | $25.91 | 35 |